A leucine residue in the C terminus of human parainfluenza virus type 3 matrix protein is essential for efficient virus-like particle and virion release

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13173-13188

  Zhang, Guangyuan ^a   Zhang, Shengwei ^a   Ding, Binbin ^a   Yang, Xiaodan ^a   Chen, Longyun ^a   Yan, Qin ^a   Jiang, Yanliang ^a   Zhong, Yi ^a   Chen, Mingzhou ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; MATRIX PROTEIN; MUTANT PROTEIN; VIROSOME;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOPRECIPITATION; NONHUMAN; OLIGOMERIZATION; PARAINFLUENZA VIRUS 3; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSMISSION ELECTRON MICROSCOPY; UBIQUITINATION; VIRION; VIRUS LIKE AGENT; VIRUS RELEASE; CELL LINE; DNA MUTATIONAL ANALYSIS; GENETICS; HUMAN; HUMAN PARAINFLUENZA VIRUS 3; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

CELL LINE; DNA MUTATIONAL ANALYSIS; HUMANS; LEUCINE; MICROSCOPY, ELECTRON, TRANSMISSION; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; MUTATION, MISSENSE; PARAINFLUENZA VIRUS 3, HUMAN; VIRAL MATRIX PROTEINS; VIRION; VIROSOMES; VIRUS RELEASE;

EID: 84908377017     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01485-14     Document Type: Article

References (66)

1. Peeples M. 1991. Paramyxovirus M proteins: pulling it all together and taking it on the road, p 427-456. In Kingsbury D (ed), The paramyxoviruses. Plenum Press, New York, NY.
2. Mebatsion T, Weiland F, Conzelmann KK. 1999. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 73:242-250.
3. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, Cattaneo R. 1998. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17:3899-3908. http://dx.doi.org/10.1093/emboj/17.14.3899.
4. Freed EO. 2002. Viral late domains. J. Virol. 76:4679-4687. http://dx.doi.org/10.1128/JVI.76.10.4679-4687.2002.
5. Schmitt AP, Leser GP, Waning DL, Lamb RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76:3952-3964. http://dx.doi.org/10.1128/JVI.76.8.3952-3964.2002.
6. Schmitt AP, Lamb RA. 2004. Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283:145-196.
7. Coronel EC, Murti KG, Takimoto T, Portner A. 1999. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J. Virol. 73:7035-7038.
8. Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T. 2004. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325:1-10. http://dx.doi.org/10.1016/j.virol.2004.04.019.
9. Runkler N, Pohl C, Schneider-Schaulies S, Klenk HD, Maisner A. 2007. Measles virus nucleocapsid transport to the plasma membrane requires stable expression and surface accumulation of the viral matrix protein. Cell. Microbiol. 9:1203-1214. http://dx.doi.org/10.1111/j.1462-5822.2006.00860.x.
10. Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC. 2007. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol. J. 4:1. http://dx.doi.org/10.1186/1743-422X-4-1.
11. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. 2006. Requirements for the assembly and release of Newcastle disease virus-like particles. J. Virol. 80:11062-11073. http://dx.doi.org/10.1128/JVI.00726-06.
12. Harty RN, Paragas J, Sudol M, Palese P. 1999. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J. Virol. 73:2921-2929.
13. Timmins J, Scianimanico S, Schoehn G, Weissenhorn W. 2001. Vesicular release of Ebola virus matrix protein VP40. Virology 283:1-6. http://dx.doi.org/10.1006/viro.2001.0860.
14. Gómez-Puertas P, Albo C, Perez-Pastrana E, Vivo A, Portela A. 2000. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74: 11538-11547. http://dx.doi.org/10.1128/JVI.74.24.11538-11547.2000.
15. Parent LJ, Bennett RP, Craven RC, Nelle TD, Krishna NK, Bowzard JB, Wilson CB, Puffer BA, Montelaro RC, Wills JW. 1995. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69:5455-5460.
16. Puffer BA, Parent LJ, Wills JW, Montelaro RC. 1997. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71:6541-6546.
17. Dorweiler IJ, Ruone SJ, Wang H, Burry RW, Mansky LM. 2006. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release. J. Virol. 80:3634-3643. http://dx.doi.org/10.1128/JVI.80.7.3634-3643.2006.
18. Heidecker G, Lloyd PA, Fox K, Nagashima K, Derse D. 2004. Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. J. Virol. 78:6636-6648. http://dx.doi.org/10.1128/JVI.78.12.6636-6648.2004.
19. Wang H, Machesky NJ, Mansky LM. 2004. Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release. J. Virol. 78:1503-1512. http://dx.doi.org/10.1128/JVI.78.3.1503-1512.2004.
20. Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN. 2003. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J. Virol. 77:1812-1819. http://dx.doi.org/10.1128/JVI.77.3.1812-1819.2003.
21. Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 68:6605-6618.
22. Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O. 2004. Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res. 100:249-255. http://dx.doi.org/10.1016/j.virusres.2003.11.017.
23. Chen BJ, Lamb RA. 2008. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372:221-232. http://dx.doi.org/10.1016/j.virol.2007.11.008.
24. Craven RC, Harty RN, Paragas J, Palese P, Wills JW. 1999. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73:3359-3365.
25. Irie T, Licata JM, Harty RN. 2005. Functional characterization of Ebola virus L-domains using VSV recombinants. Virology 336:291-298. http://dx.doi.org/10.1016/j.virol.2005.03.027.
26. Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA. 2005. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 79:2988-2997. http://dx.doi.org/10.1128/JVI.79.5.2988-2997.2005.
27. Irie T, Shimazu Y, Yoshida T, Sakaguchi T. 2007. The YLDL sequence within Sendai virusMprotein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J. Virol. 81: 2263-2273. http://dx.doi.org/10.1128/JVI.02218-06.
28. Ciancanelli MJ, Basler CF. 2006. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J. Virol. 80:12070-12078. http://dx.doi.org/10.1128/JVI.01743-06.
29. Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, Broder CC. 2008. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol. J. 5:137. http://dx.doi.org/10.1186/1743-422X-5-137.
30. Zhang S, Chen L, Zhang G, Yan Q, Yang X, Ding B, Tang Q, Sun S, Hu Z, Chen M. 2013. An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation. J. Virol. 87:12457-12470. http://dx.doi.org/10.1128/JVI.01565-13.
31. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B. 2010. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog. 6:e1001186. http://dx.doi.org/10.1371/journal.ppat.1001186.
32. Shtanko O, Imai M, Goto H, Lukashevich IS, Neumann G, Watanabe T, Kawaoka Y. 2010. A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J. Virol. 84:5415-5422. http://dx.doi.org/10.1128/JVI.02417-09.
33. Bieniasz PD. 2006. Late budding domains and host proteins in enveloped virus release. Virology 344:55-63. http://dx.doi.org/10.1016/j.virol.2005.09.044.
34. Calistri A, Del Vecchio C, Salata C, Celestino M, Celegato M, Gottlinger H, Palu G, Parolin C. 2009. Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress. J. Cell. Physiol. 218:175-182. http://dx.doi.org/10.1002/jcp.21587.
35. Hoenen T, Biedenkopf N, Zielecki F, Jung S, Groseth A, Feldmann H, Becker S. 2010. Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J. Virol. 84: 7053-7063. http://dx.doi.org/10.1128/JVI.00737-10.
36. Martin-Serrano J. 2007. The role of ubiquitin in retroviral egress. Traffic 8:1297-1303. http://dx.doi.org/10.1111/j.1600-0854.2007.00609.x.
37. Ott DE, Coren LV, Chertova EN, Gagliardi TD, Schubert U. 2000. Ubiquitination of HIV-1 andMuLVGag. Virology 278:111-121. http://dx.doi.org/10.1006/viro.2000.0648.
38. Pohl C, Duprex WP, Krohne G, Rima BK, Schneider-Schaulies S. 2007. Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J. Gen. Virol. 88:1243-1250. http://dx.doi.org/10.1099/vir.0.82578-0.
39. Zhadina M, McClure MO, Johnson MC, Bieniasz PD. 2007. Ubiquitindependent virus particle budding without viral protein ubiquitination. Proc. Natl. Acad. Sci. U. S. A. 104:20031-20036. http://dx.doi.org/10.1073/pnas.0708002104.
40. Wang D, Harmon A, Jin J, Francis DH, Christopher-Hennings J, Nelson E, Montelaro RC, Li F. 2010. The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. J. Virol. 84:4673-4681. http://dx.doi.org/10.1128/JVI.02306-09.
41. Teng MN, Collins PL. 1998. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J. Virol. 72:5707-5716.
42. Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. 2001. Role of matrix and fusion proteins in budding of Sendai virus. J. Virol. 75:11384-11391. http://dx.doi.org/10.1128/JVI.75.23.11384-11391.2001.
43. Justice PA, Sun W, Li Y, Ye Z, Grigera PR, Wagner RR. 1995. Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J. Virol. 69:3156-3160.
44. Timmins J, Schoehn G, Kohlhaas C, Klenk HD, Ruigrok RW, Weissenhorn W. 2003. Oligomerization and polymerization of the filovirus matrix protein VP40. Virology 312:359-368. http://dx.doi.org/10.1016/S0042-6822(03)00260-5.
45. McPhee HK, Carlisle JL, Beeby A, Money VA, Watson SM, Yeo RP, Sanderson JM. 2011. Influence of lipids on the interfacial disposition of respiratory syncytial virus matrix protein. Langmuir 27:304-311. http://dx.doi.org/10.1021/la104041n.
46. Gaudin Y, Barge A, Ebel C, Ruigrok RW. 1995. Aggregation of VSV M protein is reversible and mediated by nucleation sites: implications for viral assembly. Virology 206:28-37. http://dx.doi.org/10.1016/S0042-68 22(95)80016-6.
47. Scianimanico S, Schoehn G, Timmins J, Ruigrok RH, Klenk HD, Weissenhorn W. 2000. Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J. 19:6732-6741. http://dx.doi.org/10.1093/emboj/19.24.6732.
48. Hoenen T, Volchkov V, Kolesnikova L, Mittler E, Timmins J, Ottmann M, Reynard O, Becker S, Weissenhorn W. 2005. VP40 octamers are essential for Ebola virus replication. J. Virol. 79:1898-1905. http://dx.doi.org/10.1128/JVI.79.3.1898-1905.2005.
49. Bornholdt ZA, Noda T, Abelson DM, Halfmann P, Wood MR, Kawaoka Y, Saphire EO. 2013. Structural rearrangement of Ebola virus VP40 begets multiple functions in the virus life cycle. Cell 154:763-774. http://dx.doi.org/10.1016/j.cell.2013.07.015.
50. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure 22:136-148. http://dx.doi.org/10.1016/j.str.2013.10.013.
51. Battisti AJ, Meng G, Winkler DC, McGinnes LW, Plevka P, Steven AC, Morrison TG, Rossmann MG. 2012. Structure and assembly of a paramyxovirus matrix protein. Proc. Natl. Acad. Sci. U. S. A. 109:13996-14000. http://dx.doi.org/10.1073/pnas.1210275109.
52. Demirov DG, Freed EO. 2004. Retrovirus budding. Virus Res. 106:87-102. http://dx.doi.org/10.1016/j.virusres.2004.08.007.
53. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20:395-425. http://dx.doi.org/10.1146/annurev.cellbio.20.010403.102350.
54. Utley TJ, Ducharme NA, Varthakavi V, Shepherd BE, Santangelo PJ, Lindquist ME, Goldenring JR, Crowe JE, Jr. 2008. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. U. S. A. 105:10209-10214. http://dx.doi.org/10.1073/pnas.0712144105.
55. Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM, Harty RN, Schnell MJ. 2008. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J. Virol. 82:9730-9738. http://dx.doi.org/10.1128/JVI.00889-08.
56. Jayakar HR, Murti KG, Whitt MA. 2000. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 74:9818-9827. http://dx.doi.org/10.1128/JVI.74.21.9818-9827.2000.
57. Joshi A, Munshi U, Ablan SD, Nagashima K, Freed EO. 2008. Func-tional replacement of a retroviral late domain by ubiquitin fusion. Traffic 9:1972-1983. http://dx.doi.org/10.1111/j.1600-0854.2008.00817.x.
58. Watanabe H, Tanaka Y, Shimazu Y, Sugahara F, Kuwayama M, Hiramatsu A, Kiyotani K, Yoshida T, Sakaguchi T. 2005. Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors. Microbiol. Immunol. 49:835-844. http://dx.doi.org/10.1111/j.1348-0421.2005.tb03672.x.
59. Dowlatshahi DP, Sandrin V, Vivona S, Shaler TA, Kaiser SE, Melandri F, Sundquist WI, Kopito RR. 2012. ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding. Dev. Cell 23: 1247-1254. http://dx.doi.org/10.1016/j.devcel.2012.10.023.
60. Keren-Kaplan T, Attali I, Estrin M, Kuo LS, Farkash E, Jerabek-Willemsen M, Blutraich N, Artzi S, Peri A, Freed EO, Wolfson HJ, Prag G. 2013. Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus budding. EMBO J. 32:538-551. http://dx.doi.org/10.1038/emboj.2013.4.
61. Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ. 2001. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J. Virol. 75:10623-10629. http://dx.doi.org/10.1128/JVI.75.22.10623-10629.2001.
62. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97:13871-13876. http://dx.doi.org/10.1073/pnas.250277297.
63. Timmins J, Schoehn G, Ricard-Blum S, Scianimanico S, Vernet T, Ruigrok RW, Weissenhorn W. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326:493-502. http://dx.doi.org/10.1016/S0022-2836(02)01406-7.
64. Zhadina M, Bieniasz PD. 2010. Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog. 6:e1001153. http://dx.doi.org/10.1371/journal.ppat.1001153.
65. Harrison MS, Schmitt PT, Pei Z, Schmitt AP. 2012. Role of ubiquitin in parainfluenza virus 5 particle formation. J. Virol. 86:3474-3485. http://dx.doi.org/10.1128/JVI.06021-11.
66. Waning DL, Schmitt AP, Leser GP, Lamb RA. 2002. Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J. Virol. 76:9284-9297. http://dx.doi.org/10.1128/JVI.76.18.9284-9297.2002.